Search
enVVeno Medical Corp
NVNOAdd to Watchlist
11.110USD
+0.310+2.80%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
7.29MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02No earnings forecast score is currently available for enVVeno Medical Corp. The Biotechnology & Medical Research industry's average is 8.14. The average price target is 12.50, with a high of 12.50 and a low of 12.50.
Analyst Rating
Based on
1
analysts
Hold
Current Rating
12.500
Target Price
+1517.29%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
enVVeno Medical Corp
NVNO
1
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is enVVeno Medical Corp's price target?
Analysts forecast that enVVeno Medical Corp's price target is USD 12.50, with the highest forecast at USD 12.50 and the lowest forecast at USD 12.50.
How have enVVeno Medical CorpNVNO's recent earnings per share performed?
The market expectation was USD -5.89, while enVVeno Medical CorpNVNO's earnings per share (EPS) for the previous quarter was USD -6.05. EPS for the next quarter is expected at USD -0.26.
What is the analyst rating for enVVeno Medical Corp?
Based on the ratings of enVVeno Medical Corp's stock from 1 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.